Trial intelligence / Profile preview

Nocturnal vs Morning Administration of Valsartan and Amlodipine in Non-dipper Hypertensive Patients

NCT01091753Phase 4Completed

Sponsor
Yonsei University
Start
Mar 2008
Primary completion
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of valsartan and amlodipine in hypertension (HTN) (2 arms), sponsored by Yonsei University. Primary endpoint: Intima Media Thickness at 36 months. Started Mar 2008; status: completed.

02

Drugs

valsartanamlodipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01091753.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01091753.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call